KR102198970B1 - 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용 - Google Patents

저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용 Download PDF

Info

Publication number
KR102198970B1
KR102198970B1 KR1020190070083A KR20190070083A KR102198970B1 KR 102198970 B1 KR102198970 B1 KR 102198970B1 KR 1020190070083 A KR1020190070083 A KR 1020190070083A KR 20190070083 A KR20190070083 A KR 20190070083A KR 102198970 B1 KR102198970 B1 KR 102198970B1
Authority
KR
South Korea
Prior art keywords
low
dose radiation
dose
mus musculus
genes
Prior art date
Application number
KR1020190070083A
Other languages
English (en)
Other versions
KR20200142783A (ko
Inventor
남선영
김지영
조성준
홍은희
Original Assignee
한국수력원자력 주식회사
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국수력원자력 주식회사 filed Critical 한국수력원자력 주식회사
Priority to KR1020190070083A priority Critical patent/KR102198970B1/ko
Publication of KR20200142783A publication Critical patent/KR20200142783A/ko
Application granted granted Critical
Publication of KR102198970B1 publication Critical patent/KR102198970B1/ko

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

본 발명은 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10으로 이루어진 군으로부터 선택된 하나 이상의 유전자인, 저선량 방사선 피폭 진단용 유전자에 관한 것이다.
본 발명에 따르면, 저선량 방사선에 특이적으로 반응하는 지표 유전자를 확인함으로써 이러한 지표 유전자를 이용하여 저선량 방사선에 의한 생체 반응 및 영향을 진단할 수 있는 효과가 있다.

Description

저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용{DETECTION OF GENE GROUP SPECIFICALLY REACTING TO LOW-DOSE RADIATION AND IT'S APPLICATION}
본 발명은 저선량 방사선에 특이적으로 반응하는 지표 유전자에 관한 것으로서, 더욱 상세하게는 이러한 지표 유전자를 이용하여 저선량 방사선에 의한 생체 반응 및 영향을 예측 진단하는 것에 관한 것이다.
고선량 및 고선량률 방사선에 의한 생물학적 영향은 DNA 손상, 혈구 세포의 사멸 등으로 비교적 잘 알려져 있지만 저선량 방사선에 의한 영향은 여전히 논쟁 중에 있다. 특히, 우리나라의 경우 전력 생산의 상당 부분을 원자력 발전에 의존하고 있을 뿐 아니라, 건축물의 비파괴적 구조 진단 내지 질병 진단 등을 위하여 소형의 방사선 조사 기기들이 산업현장에서 사용되고 있으며, 이에 따라 방사선 관련 작업 종사자의 수가 증가하고 있다. UN과학위원회 (UNSCEAR) 2000년 보고서에서 따르면 100 mGy 이하의 방사선을 저선량 방사선으로, 0.1 mGy/min (6 mGy/h) 이하의 방사 선량률을 저선량률 방사선으로 정의하고 있다. 이렇게 산업 및 의료용 방사선의 사용 증가 등으로 인해 일반인들의 저선량 방사선 노출에 대한 관심이 높아지고 있음에도 불구하고 저선량 방사선에 의한 생물학적인 영향과, 그 과정에서 반응하는 특이 유전자에 대한 연구는 부재한 상황이다.
본 발명은 저선량 방사선에 특이적으로 반응하는 지표 유전자를 확인함으로써 상기 지표 유전자를 저선량 방사선에 의한 생체 내 영향과 반응을 예측하는 지표 유전자로 제공하는 것을 일 목적으로 한다.
또한 본 발명은 상기 지표 유전자를 이용해 저선량 방사선에의 피폭여부를 진단하는 것을 다른 목적으로 한다.
그리고 본 발명은 상기 지표 유전자를 바이오 마커로 포함하는 저선량 방사선 진단용 DNA 칩 및 상기 지표 유전자에 특이적으로 결합하는 프라이머 또는 프로브를 포함하는 저선량 방사선 피폭 진단용 키트를 제공하는 것을 또 다른 목적으로 한다.
상기 목적을 달성을 위하여 본 발명은 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10로 이루어진 군으로부터 선택된 하나 이상의 유전자인, 저선량 방사선에 의한 생체 반응 진단용 유전자를 제공한다.
아울러 상기 목적 달성을 본 발명은 동물로부터 분리된 시료에서 상기 유전자로 이루어진 군으로부터 선택된 하나 이상의 유전자의 발현 수준을 측정하는 단계를 포함하는 저선량 방사선에 의한 영향의 진단 방법을 제공한다. 또한 상기의 유전자로 이루어진 군으로부터 선택된 하나 이상의 유전자를 바이오 마커로 포함하는 저선량 방사선 피폭 진단용 DNA 칩 및 상기의 유전자로 이루어진 군으로부터 선택된 하나 이상의 유전자에 특이적으로 결합하는 프라이머 또는 프로브를 포함하는 저선량 방사선 피폭 진단용 키트를 제공한다.
상기와 같은 본 발명에 따르면, 저선량 방사선에 특이적으로 반응하는 지표 유전자를 확인함으로써 이러한 지표 유전자를 이용하여 저선량 방사선에 의한 생체 영향 및 반응을 예측할 수 있는 효과가 있다.
도 1은 본 발명의 일 실시예에 따른 C57BL/6 마우스에 저선량 방사선을 조사한 경우 C57BL/6 마우스의 혈구와 비장에 미치는 영향을 나타낸 그래프로서 도 1A는 백혈구의 밀도, 도 1B는 적혈구의 밀도, 도 1C는 혈소판 밀도, 도 1D는 비장의 무게, 도 1E는 비장 세포의 수를 나타낸다.
도 2는 본 발명의 일 실시예에 따른 저선량 방사선에 노출된 비장 세포의 생존률을 나타낸다.
도 3은 본 발명의 일 실시예에 따른 저선량 방사선을 C57BL/6 마우스에 조사한 경우 저선량 방사선에 의해 발현 변화를 보이는 유전자의 수를 나타낸 것으로서, 도 3A는 저선량 방사선에 조사된 경우에 발현 변화를 보이는 유전자의 수를 나타내는 막대 그래프, 도 3B는 발현 변화를 보이는 유전자의 수를 나타낸 벤다이어그램이다.
도 4는 본 발명의 일 실시예에 따른 C57BL/6 마우스에 저선량 방사선을 조사한 경우 RNA 시퀀싱 프로파일 정보로 계층분석을 실시한 결과이다.
이하, 본 발명의 실시예를 상세히 설명한다.
본 발명의 일 실시예에 따른 저선량 방사선 피폭 진단용 유전자는 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10로 이루어진 군으로부터 선택된 하나 이상의 유전자에 해당한다. 상기 저선량 방사선은 0.1 Gy 이하일 수 있고, 바람직하게는 0.1 Gy 이다.
상기 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3 및 Rragb 유전자는 저선량률의 저선량 방사선에의 피폭 여부만을 진단할 수 있는 저선량 방사선 피폭 진단용 유전자에 해당한다. 상기 저선량률은 0.1 mGy/min 이하일 수 있고 보다 바람직하게는 0.083 mGy/min이다.
도 3의 B를 참조하면, 상기 저선량률의 저선량 방사선에의 피폭 여부만을 진단할 수 있는 유전자는 벤다이어 그램의 주황색 원(0.1Gy-Cronic rate, 0.1Gy-C) 중 저선량 방사선(0.1 Gy)을 고선량률(Acute rate)로 조사한 경우인 하늘색 원(0.1Gy-A) 및 고선량 방사선(2Gy)을 고선량률(Acute rate)로 조사한 경우인 연두색 원(2Gy-A)과 겹쳐지지 않는 영역에 존재 한다. 상기 겹쳐지지 않는 영역의 유전자들 중 178개는 저선량률의 저선량 방사선을 조사했을 때에만 그 발현이 방사선을 조사하지 않은 대조군에 비해 1.5배 이상 증가한 유전자들을 의미한다. 상기 저선량률의 저선량 방사선에의 피폭 여부만을 진단할 수 있는 저선량 방사선 피폭 진단용 유전자 리스트들은 상기 178개 유전자들 중에서 선정된 일부에 해당한다.
상기 저선량률의 저선량 방사선에의 피폭 여부만을 진단할 수 있는 저선량 방사선 피폭 진단용 유전자 리스트들을 제외한 나머지인 상기 Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10 유전자는 저선량률의 저선량 방사선을 조사한 경우 및 고선량률의 저선량 방사선을 조사한 경우 둘 다 대조군에 비해 발현이 증가하는, 저선량 방사선 피폭 진단용 유전자에 해당한다.
도 3의 B를 참조하면, 벤다이어그램 중 주황색 원(0.1Gy-C)과 하늘색 원(0.1Gy-A)이 서로 겹치는 영역에 존재하며, 고선량 방사선을 조사한 경우인 연두색 원(2Gy-A)와 겹치지 않는 영역에 존재하는 유전자로서 상기 영역에 기재된 수치인 164는 그 발현이 1.5배 이상 증가한 유전자의 개수이다. 상기 유전자 리스트는 상기 164개 유전자 중 선정된 일부에 해당한다.
본 발명의 다른 실시예에 따른 저선량 방사선 피폭 진단 방법은, 동물로부터 분리된 시료에서 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10로 이루어진 군으로부터 선택된 하나 이상의 유전자의 발현 수준을 측정하는 단계를 포함한다. 상기 유전자의 발현 수준의 측정은 PCR(Polymerase chain reaction) 또는 RNA 시퀀싱(RNA Sequencing)에 의해 이루어질 수 있다.
상기 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10 유전자는 그 발현 수준이 저선량 방사선에 피폭되지 않은 대조군에 비해 1.5배 이상 증가한 경우 저선량 방사선에 피폭되었다고 진단할 수 있다.
특히 상기 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3 및 Rragb유전자는 저선량률의 저선량 방사선에의 피폭 여부만을 진단할 수 있다. 이러한 유전자들은 도 3의 B 에 제시된 주황색원 중 다른 원들과 겹치지 않은 영역에 기재된 178개의 유전자들 중에 선정된 일부에 해당한다.
본 발명의 또 다른 실시예는 Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10으로 이루어진 군으로부터 선택된 하나 이상의 유전자를 바이오 마커로 포함하는 저선량 방사선 피폭 진단용 DNA 칩을 제공한다. 또한 상기 군으로부터 선택된 하나 이상의 유전자에 특이적으로 결합하는 프라이머 또는 프로브를 포함하는 저선량 방사선 피폭 진단용 키트를 제공한다.
이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 이들 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 제한되는 것으로 해석되지는 않는 것은 당 업계에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.
실시예 1. 방사선 조사 후 혈구 및 비장 세포의 수 분석
7주령의 C57BL/6 마우스(수컷)를 일주일 순화기간을 거친 후, 마우스 전신에 방사선을 전혀 조사지 않은 대조군, 실험군으로 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우(0.1Gy-C), 고선량률의 저선량 방사선 (137Cs, 208 mGy/min, 0.1 Gy)을 조사한 경우(0.1Gy-A) 고선량률의 고선량 방사선 (137Cs, 208 mGy/min, 2 Gy)을 조사한 경우(2Gy-A)을 준비하였다. 그 후 생물학적 영향 평가를 위해, 2, 7, 14일 째 혈구 분석을 실시하고, 비장의 무게를 측정한 후 혈구 및 비장 세포의 수를 분석하였다. 그 결과 저선량 방사선에 의해서는 뚜렷한 혈구 및 비장 세포의 수 변화가 확인되지 않았다. (도 1 참조)
실시예 2
실시예 1과 동일한 조건으로 방사선을 조사한 후 4시간 째인 마우스의 비장을 채취하여 단일세포로 만든 다음 배양하여 72시간 후에 비장세포의 생존능을 평가하였다. 그 결과 저선량 방사선에 의해서는 대조군과 비교하여 뚜렷한 영향의 차이를 확인할 수 없었다. (도 2 참조).
실시예 3
실시예 1과 동일한 조건으로 방사선을 조사한 후 4시간 째인 마우스의 비장시료를 채취한 다음, 이를 대상으로 RNA 시퀀싱 프로파일 분석을 수행하였다. 그 결과 대조군 대비 1.5 배 이상 증가한 유전자들의 수를 확인하였다. 도 3의 A를 참조하면, 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우(0.1Gy-C) 600개의 유전자의 발현이 증가하였다. 고선량률의 저선량 방사선 (137Cs, 208 mGy/min, 0.1 Gy)을 조사한 경우(0.1Gy-A)에는 1612개 유전자의 발현이 증가하였다. 그리고 고선량률의 고선량 방사선 (137Cs, 208 mGy/min, 2 Gy)을 조사한 경우(2Gy-A)에는 1314개의 유전자의 발현이 증가하였다.
도 3의 B를 참조하면, 벤다이어그램 중 주황색 원은 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우(0.1Gy-C)로서 특히 다른 원 들과 겹지지 않는 영역에 기재된 수치는 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우에만 그 발현이 1.5배 이상 증가한 유전자의 개수에 해당한다. 즉, 178은 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우에만 그 발현이 1.5배 이상 증가하는 유전자의 개수에 해당한다. 상기 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우에만 그 발현이 1.5배 이상 증가한 유전자들 중 의미 있는 유전자들을 일부 선정하였고 이를 표 1에 나타내었다.
Genes induced by 0.1 Gy irradiation at low-dose rate
Up Zbtb16, Slc15a2, C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb
그리고 벤다이어그램 중 주황색 원과 하늘색 원이 서로 겹치는 영역에 기재된 수치는 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우 및 고선량률의 저선량 방사선 (137Cs, 208 mGy/min, 0.1 Gy)을 조사한 경우 둘 다 대조군에 비해 발현이 1.5배 이상 증가하는 유전자 개수에 해당한다. 즉, 164는 그 발현이 1.5배 이상 증가한 유전자의 개수이다. 상기의 저선량률의 저선량 방사선 (137Cs, 0.083 mGy/min, 0.1 Gy)을 조사한 경우 및 고선량률의 저선량 방사선 (137Cs, 208 mGy/min, 0.1 Gy)을 조사한 경우 공통적으로 대조군에 비해 그 발현이 1.5배 이상 증가하는 유전자들 중 의미 있는 유전자들을 일부 선정하였고 이를 이하의 표 2에 나타내었다.
Genes induced by 0.1 Gy irradiation
Up Nlrp12, Trem1, Siglece, Hp, Mmp9, Clec4d, Klf5, Mpo, Gcnt2, Ccl6, Reep6, Emilin2, Ccr1, Rab27b, P2ry1 및 Pcdh10
그리고 방사선에 의해 조절된 유전자 발현 프로파일의 유사성을 계층분석 (hierarchical clustering)을 통해 확인한 결과, 저선량률의 저선량 방사선에 노출된 시료의 RNA 발현 프로파일이 대조군에 가장 가까운 것으로 나타났다. (도 4 참조). 이는 대조군과 가깝지만 완전히 일치하는 것은 아니기 때문에 비장의 무게 또는 혈구의 밀도 변화를 통해 감지할 수 없는 저선량률의 저선량 방사선에의 노출을, 유전자 발현 프로파일을 통해서 진단하는 지표로 사용할 수 있다. 또한 1.5배 이상 증가한 유전자들 중 생체에 긍정적인 효과를 미치는 유전자들로 향후, 저선량에 의한 생체 보호 효과 연구의 기초로 삼을 수 있다.
<110> Korea Hydro & Nuclear Power Co. Ltd. <120> DETECTION OF GENE GROUP SPECIFICALLY REACTING TO LOW-DOSE RADIATION AND IT'S APPLICATION <130> P19-E055 <160> 24 <170> KoPatentIn 3.0 <210> 1 <211> 2022 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(2022) <223> Mus musculus zinc finger and BTB domain containing 16 (Zbtb16) <400> 1 atggatctga caaagatggg gatgatccag ctgcagaacc ctagccaccc cacggggctg 60 ctgtgcaagg ccaatcagat gcgactggct gggactttgt gcgatgtggt catcatggtg 120 gacagccagg agttccatgc ccaccggacg gtgctagcct gcaccagcaa gatgtttgag 180 atcctcttcc accgaaacag ccagcactat actctagact tcctctcgcc aaaaaccttc 240 cagcagatcc tggagtacgc ctacacggcc acactgcaag ccaaggcgga ggacctggat 300 gacctgctgt atgcagctga gattttagag atcgaatacc tggaggagca gtgcctgaag 360 atcctggaga ccatccaggc atctgatgac aatgacacag aggccaccat ggctgacggt 420 gggggcgaag aagaagagga ccgtaaggct cgatacctca agaacatctt tatctcgaag 480 cattccagcg aggagagtgg ctacgccagt gtggctggac agagcctccc tgggcccatg 540 gtggaccaga gcccctcagt ctccacctct ttcggtctct cagccatgag tcctaccaag 600 gcagccgtgg acagcttgat gagtatagga cagtcactcc tgcaaggaac tcttcagcca 660 cctgcagggc ctgaggagcc cacactggca gggggtgggc gacaccctgg ggtggctgag 720 gtgaagatgg aaatgatgca ggtagatgaa gcccctggcc aggacagccc tggggcagct 780 gagtctagca tctcaggagg gatgggggac aagcttgaag agaggagcaa agaggggcct 840 gggaccccga ctcgaggcag tgtcatcact agtgccagag agctgcatta tgggagagag 900 gagagtggtg agcagctctc gcctcctgtt gaagctggcc agggaccccc tgggcggcag 960 gagcccctgg cacccccagt ggagaagcat ttgggtatct actcggtgct gcccaaccac 1020 aaggccgatg ctgtgttgag catgccgtct tcagtgacgt ccggtctcca tgtgcaacct 1080 gccctggcag tctccatgga cttcagcacc tacgggggtc tgctgcctca gggcttcatc 1140 cagagggagc tgttcagcaa gctgggggag ctggctgtgg gcatgaaggc tgagagccgc 1200 cctctggggg agcagtgcag cgtgtgtggg gtcgagcttc cggacaacga ggcagtggag 1260 cagcacagga aactgcacag tgggatgaaa acatacgggt gtgaactctg cggaaaacgg 1320 ttcctggaca gtttgcgact gagaatgcat ttactggctc attcagcggg tgccaaagcc 1380 tttgtgtgtg atcaatgcgg tgcccagttc tcaaaggagg atgccctgga gacacacaga 1440 cagacccata ctggcacgga catggctgtc ttctgtctgc tgtgtgggaa acgctttcag 1500 gcacaaagcg cactccagca gcacatggag gtccacgcag gcgtgcgcag ctatatttgc 1560 agtgagtgca accgcacctt ccccagccac acggctctca agcgccacct tcgctcacat 1620 acaggtgacc acccatatga gtgtgagttc tgcggcagct gcttccggga tgagagcaca 1680 ctcaagagcc acaagcgcat ccacacaggg gagaagccct atgagtgtaa tggctgtggc 1740 aagaagttca gcctcaagca ccagttggag acgcactaca gggttcacac aggtgagaag 1800 ccctttgagt gcaaactctg ccaccagcgc tcccgagact actcggccat gatcaagcac 1860 ctgagaacac acaacggtgc ctcgccatac cagtgtacca tctgcacgga atactgcccc 1920 agcctctcct ccatgcagaa acacatgaag ggccacaagc cggaggagat cccacctgac 1980 tggaggatag agaagacgta cctctacctg tgttatgtgt ga 2022 <210> 2 <211> 2223 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(2223) <223> Mus musculus solute carrier family 15 (H+/peptide transporter), member 2 (Slc15a2) <400> 2 atgcttgagg agagagagag taaggagcca gccatgaatc ctttccagaa aaatgagtcc 60 aaggaaacgc tcttttcacc tgtctctact gaagagatgc tgcctggacc tccaagccct 120 ccaaagaagt caactccgaa gctcttcggc tctagctacc cactcagcat cgccttcatt 180 gtggtgaacg aattctgcga gcgattttcc tattatggca tgaaagctgt gttgaccttg 240 tatttcctgt acttcctgca ctggaatgaa gacacgtcca catctgtcta ccatgccttc 300 agcagcctct gctatttcac ccccatcttg ggagcagcga ttgctgactc ctggctggga 360 aaattcaaga caatcatcta tctgtccctg gtgtatgttc ttggccatgt attcaagtct 420 ttgggtgcca taccaatact gggaggaaaa atgctacata caatcttatc attggttggc 480 ctgagtctca tagctctggg aacaggaggt atcaaaccct gtgtggcagc ttttggcgga 540 gaccagtttg aagaggaaca tgcagaggca cggactagat acttctcggt cttctacctc 600 tccatcaatg cagggagctt gatttctatg ttcatcacac ccatgctaag aggggatgtg 660 aagtgttttg gcgaagactg ctatgcattg gcttttggga ttccaggatt gctcatggtg 720 ctggcacttg ttgtgtttgc aatgggaagc aagatgtaca gaaaaccgcc tcctgaaggg 780 aacatagtgg ctcaagttac caaatgtata tggtttgcta tctgcaaccg cttcaggaac 840 cgttctgagg acattccaaa gcgacaacat tggctagact gggcagcaga aaaataccca 900 aagcacctca ttatggacgt gaaggcactg accaggatac tgttccttta tatcccactg 960 cccatgttct gggctctttt ggaccaacag ggctcacggt ggactctgca agctaacaaa 1020 atggatggcg atttgggatt ttttgtactt cagccggatc agatgcaggt gctaaatccc 1080 tttctggtcc ttgtcttcat cccattgttt gaccttgtca tttatcggct gatctccaag 1140 tgcggagtta acttctcgtc actcaggaaa atggctgttg gtatgatcct agcgtgcttg 1200 gcatttgcag ttgcagcgct tgtagagata aaaataaatg gaatgatcca tcctcagcca 1260 gcttcccaag agatttttct gcaagtcctg aacttggcag atggtgaaat agaggtgaca 1320 gtgcagggaa acagaaataa tcctctcttg gtggagtcca tcagctcttt tcagaacaca 1380 acacactatt cgaaactacg cctggagaca aaaagccaag acttacattt tcatctgaag 1440 tacaacaact tgtctgtcca caatgagtac tctgtagagg agaagaactg ttaccagttg 1500 gtggttcatg agaatggaga aagtctctcc agtatgctgg taaaggacac aggaatcaaa 1560 ccagccaatg ggatgacagc catcaggttt attaacactt tgcataaaga catgaatatt 1620 tccttggatg ccaatgctcc tctcagcgtg ggcaaagact atggagtgtc tgagtacaga 1680 actgtgcaaa gaggaaagta tcctgcagtg cattgtgaaa cggaagacaa tgtcttttct 1740 ctcaatttag gtcaactaga ctttggtaca acatatttgt ttgtgatcac taatatcacc 1800 aaccggggtc ttcaggcctg gaaggcagaa gacattccag ccaataaact atccattgca 1860 tggcagctac cacagtatgt cctggttaca gcagcagagg tcatgttttc tgtcacagga 1920 cttgaatttt cttattctca ggcaccatct agcatgaaat ctgtgctcca ggcagcctgg 1980 ctgttgaccg ttgcagttgg gaatattatt gtgctgatcg tggcacagtt cagtggcctg 2040 gtgcagtggg ctgaattcgt tttgttttcc tgcctcctgc tggtggtctg cctgatcttc 2100 tccgtcatgg gctactacta tgttcctcta aagtcagagg gtatccatga ggcaacagaa 2160 aagcagattc ctcacatcca ggggaatatg atcaacctag aaaccaagaa tacaaggctc 2220 tga 2223 <210> 3 <211> 885 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(885) <223> Mus musculus C1q and tumor necrosis factor related protein 2 (C1qtnf2) <400> 3 atgacaattt ttaaaaaggt gacaaccatg atctcctggg tactcttggc ctgtgccctt 60 ccgtgtgctg ctgacccaat gcttggtgcc tttgctcgca gggacttcca gaaggggggt 120 cctcaactag tttgcagcct gcctggtccc caaggcccac ctggccctcc aggagcacca 180 ggatcctcag gagtggtggg aagaatgggt ttccctggga aagacggcca agatggccag 240 gacggagacc ggggggacag tggagaagaa ggtccacctg gcaggacagg caaccgtgga 300 aaacaaggac caaagggcaa agctggggcc attggcagag ctggccctcg aggacccaag 360 ggggtcagtg gtacccccgg gaagcatggc acaccgggca agaagggacc taagggcaaa 420 aaaggggagc ctggcctccc aggcccctgc agctgcggca gtagccgagc caagtcggcc 480 ttttccgtgg cggtaaccaa gagctaccca cgcgagcgac tgcctatcaa gtttgacaag 540 attctgatga acgagggtgg ccactacaac gcgtccagtg gcaagttcgt ctgcagcgtg 600 ccggggatct attactttac ctatgacatt acgctggcca acaaacacct ggccatcggc 660 ctggtgcaca atggtcagta ccgcattcgg acttttgatg ccaacacggg caaccacgac 720 gtggcctcgg gctccaccat cctagctctc aaggagggtg atgaagtctg gctgcagatc 780 ttctactcag agcagaatgg cctcttctac gacccttact ggaccgacag cctgttcacc 840 ggcttcctca tctacgctga ccaaggagac cccaacgagg tatag 885 <210> 4 <211> 3174 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(3174) <223> Mus musculus desmoglein 1 alpha (Dsg1a) <400> 4 atggactggc actccttcag gatagctgcc ctgctgctca cttccctggt ggtgcttgaa 60 gttaacagtg aatttcaaat ccaggtaaga gatcataacg ccaaaaatgg taccatcaag 120 tggcattcca tcagaaggca gaaacgagaa tggatcaagt ttgctgcagc ctgtcgcgaa 180 ggtgaagaca actcaaagag aaacccaatt gccaaaattc attcagattg tgctgcaaat 240 caaccagtga cataccgcat ctcgggagtg ggaattgacc agccacctta tggaatcttc 300 attattaatc aaaaaactgg tgaaatcaat ataacatcca ttgttgatcg tgaagtcacc 360 ccctttttca ttatctactg ccgagcactg aatgcacaag gtcaagactt ggagaatcca 420 ctggagctta gagttagagt gatggatata aatgacaacc ctcctgtgtt ttcaatgact 480 acatttctag gacaaataga agaaaattct aatgcaaaca cactggtaat gaaactcaat 540 gctaccgatg ccgatgagcc aaataacttg aactcaatga tagccttcaa gatcataaga 600 caggagcctt ctgactcacc aatgttcatc atcaacagga aaactggaga aatcagaaca 660 atgaataact ttctagacag agagcaatat agccagtatt cccttgtggt gagaggctca 720 gaccgggacg gtggagcaga cggcatgtct gcagagagcg agtgcagcat caccatcctg 780 gatgtcaatg acaacatccc atacttggag cagtcatctt atgacatcac aattgaagaa 840 aatgcacttc actcacagct agtgcagatc agagtcattg atttggatga agaattctca 900 gacaactgga aggcaatcat tttctttatc tctggaaatg agggaaattg gtttgaaata 960 gaaatgaatg aaagaacaaa tgtaggaact ctgaaggttg tcaagcccct agattatgaa 1020 gccatgaaga atctacagct tagtattggt gttcggaatg tagctgaatt ccaccagtca 1080 attatttctc aatacagact cacagcaact atggtcactg tgactgtgtt aaatgtcatc 1140 gagggctctg tgttccgtcc aggttcaaag acatttgtag tagacagtag aatggaagca 1200 aatcacagag tgggagagtt tgtagctaca gacctggaca caggtcgagc ttccacaaat 1260 gttagatatg aaatgggaaa taacccagag aacctgctgg ttgttgactc aagaacaggc 1320 ataataacgt taagaaacag agttactatg gaacaatacc aaaggcttaa tggggaatat 1380 aaaggaacag tgctatcaat agatgattcc cttcagagga cctgcacggg gacaatcgtc 1440 attgaactta gtggcactgg ctgggtaact ggttcagaaa gtggtggcag ttccagtggc 1500 agtggcgatg atcgtgaccg agtgactaat ggatatcaag gcacttcttc cactgagaac 1560 ccacaacgcg tcacaggatc atggggaggc agcggcatcg atggcactcg ccctaacact 1620 aaccctttcc aaggggatcc tgatgaaacc cttgagaccc ctctctatgg agacaacgtt 1680 cacttcggtc ctgcaggcat cgggctgctc atcatggggt tcctagtctt aggattggtt 1740 ccattcctgc tgatctgctg tgattgtgga ggggcccctg gtggtggagc tggatttgaa 1800 cctgttccag aatgttctga tggagcaatt cacacgtggg ctgtagaagg gccacagcct 1860 gaaccccatg aagggataac caccatctgt gtgccacaaa tgccacctgg taatgccaat 1920 gttatagaat atattgacaa ctcaggagtt tatacaaatg aatattgtgg cagagaaatg 1980 caagatctgg gaggaggaga aagaaccaca ggatttgaac taatggatgg agttaaaaca 2040 tcagctgcac ctgagatatg ccaagaatat tcaggaacat taagaagaaa ttcaatgaga 2100 gaatgtagag atgggggtct caacatgaat ttcatggaaa gttacttctg ccagaaagcc 2160 tatgcttatg cggatgaaga tgaaggacgt ccatccaatg actgtttgct catctatgac 2220 atcgaaggtg tgggttcccc tgcaggctcc gtgggctgtt gcagtttcat tggagaagat 2280 ctagatgaga gcttcctgga taccttgggg cccaagttta agaagttggc agatatcagc 2340 ctgggaaaag aaatagactc atacccagat tctgatcctt cttggcctcc tcagagcact 2400 gaaccgatgt gtccccagca tacagagccc ctgggtagtg gacacccacc catctcccca 2460 cattttggca cgaccacagt aatttctgaa aatgcctacc actctggacc tggagtacag 2520 catcctgtac caattcctga tcctctgggc tatggcaatg tcactgtgag ggagtcctat 2580 accacctctg gcactctgaa accctctgtc cactttcatg ataatcagca ggcttcaaat 2640 gtggtggtga cagagagggt ggtgggcccc atctctggtg ctgatttgca tggcatgtta 2700 gagatacctg acttaagagg tggagcaaat gttatagtga cagaaagggt aatagcacca 2760 ggctcaagtc tacccacttc tctaaccatt cctaaccctc aagagacctc aaatgtagtt 2820 gtgacagaaa gagtgatcca accaacctct ggcatgatag gcaatctgag catgacccct 2880 gaattatcaa gtgcccacaa cgtgattgtg acagagagag tggtttctgg tgctggtatg 2940 agtgaaattg caggcactgc cggattaggg ggggttggag gcataggcag cagtggcctt 3000 gttagcacca ccatgggtgc ttctggcact gggctgaaca tgggaggaac agccactatt 3060 ggccacatga ggagctcctc tgaccatcac tttagtcaga cagttggatc tgcctccccc 3120 agcatggctc gaagtcgaat cacaaagtac aatacggtac agtatagcaa gtag 3174 <210> 5 <211> 1647 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1647) <223> Mus musculus transmembrane protease, serine 13 (Tmprss13) <400> 5 atggacagag gcagccaccg gaattcttct ccagcaagga cacctcccca ggcttcccca 60 gcaaggacat ctccagcaag ggcacctcct caggcctctc cagcaaggac acctcctcag 120 gcctctccaa caaggacacc tcctcaggcc tctccagcaa gggcacctcc tcctcaggct 180 tccccagccc gggcatctcc agcccgggca tctctagcca gggcaccacc ttccaggtca 240 tcatcgggca gatcatcatc tgccaggtca gcctccacga catcctcccc aacgagagtg 300 taccttgtta gagcaacacc agtgggggct gtccccatcc gggcatctcc tgccaggtca 360 gcaccagcca ccagggccac cagggagagc ccaggtctca gtttccccaa gttctcctgg 420 caggagaccc agaggcagct gccactcatc gggtgtgtca tccttctcat cagcctggtg 480 atctcactca tccttctctt ctacttctgg agaggccaca cagggatcaa gtacaaagag 540 ccactggaga gttgccctat ccacgcagtt cgctgtgatg gagtggtgga ctgcaaaatg 600 aagagcgatg agctgggctg tgtcaggttc gactgggaca agtccctcct gaaagtctac 660 tctgggtctt ctggcgagtg gcttcctgtc tgcagcagca gctggaacga cactgactcc 720 aagaggacct gccagcagct gggatttgac agcgcttacc gaacaactga ggtagcccac 780 agggacatca ccagcagctt cttactctcc gaatacaaca ccaccatcca ggaaagcctc 840 tataggtcgc aatgtccttc ccggcggtat gtctccctcc agtgttccca ctgtggtttg 900 agagctatga ccgggcggat cgtgggaggg gctctgacct cggagagcaa gtggccctgg 960 caagttagcc tgcacttcgg caccacccac atctgtgggg gcacactcat cgatgcccag 1020 tgggtgctca ccgctgccca ctgtttcttt gtgacccggg agaagctgct ggaggggtgg 1080 aaggtgtatg caggcaccag caacttgcac cagctgcccg aggctgcctc tatctcccag 1140 atcatcatca acggcaacta cacagatgaa caggatgact atgacattgc cctcatcagg 1200 ctgtccaagc ccctgaccct gtcagctcac atccaccctg cctgcctccc catgcatggt 1260 cagaccttcg gcctcaatga gacctgttgg atcacgggct ttggcaaaac caaggagaca 1320 gatgagaaga catctccctt cctccgagag gttcaggtca acctcattga cttcaagaag 1380 tgcaatgact acttggtcta tgacagctac cttaccccaa ggatgatgtg tgccggggat 1440 ctacgaggag ggagggactc ctgccaggga gacagtggag gacctctcgt ctgtgagcag 1500 aacaatcgct ggtacctggc aggtgtcacc agctggggca caggctgtgg ccagaaaaac 1560 aagcctggtg tgtacaccaa agtgacagaa gtacttccct ggatttacag aaagatggag 1620 agtgaggtac gattccggaa atcttaa 1647 <210> 6 <211> 876 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(876) <223> Mus musculus popeye domain containing 3 (Popdc3) <400> 6 atggagaaga attcaagctt atggaaaagc ttggtgactg aacacccact ctgcaccacc 60 tggaagcagg aggccgaagg ggccatttac cacctcgcca gtatcttgtt tgtagtaggt 120 tttatgggtg gcagtggatt ctttgggctc ctttatgtct tcagcttgct ggggctgggt 180 ttcctcagtt ctgcggtctg ggcgtgggtg gacatctgtg ccgctgacat attttcctgg 240 aattttgtgc tgtttgtcat ctgcttcatg cagttcgttc acatcgcgta tcaagttcac 300 agcataacct tcgcccgaga tttccatgtg ttgtacagct cgctcttcaa gcccctcggg 360 atccctttgc ccgtcttcag aacaattgct ctgagctctg aagtggttag tttggagaag 420 gagcactgct acgccatgca ggggaaaacc tccattgatc gactctccgt gctcatctca 480 ggaagaatca gagtgacagt cgatggcgaa tttctgcatt atatttcccc ctttcagttc 540 ctggattctc ctgagtggga ttcgctaaga cccacagagg aaggcatttt tcaggtaact 600 ctcacagcag acaccgattg ccgatatgtg tcttggagga gaaaaaaatt gtatctactc 660 tttgcgcagc atcggtacat ctcccgcctg ttttcggttt taattggcag tgacattgca 720 gataaactct atgccttgaa cgacagggtg tacataggaa agaaacatca ctatgatatt 780 cggttaccca actactacca tatgtcaact ccagacttgt ccagatcacc cctaacagaa 840 cagttccgga attccagaca acattgtaac aaatga 876 <210> 7 <211> 729 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(729) <223> Mus musculus DnaJ heat shock protein family (Hsp40) member B3 (Dnajb3) <400> 7 atggtggact actacgaggt gctgggcgtg ccgcggcagg cctcagccga ggccatccgc 60 aaggcgtacc gcaagcttgc gctcaagtgg cacccggaca agaaccccga gcacaaggag 120 gaggccgaga ggcggttcaa gcaggtggcg caggcctacg aggtcttatc ggacgtccgc 180 aagcgcgagg tgtacgaccg ctgcggcgaa gtgggcgagg tgggcggagg cggcgcggcg 240 ggcagcccgt tccacgatgc cttccagtac gtcttctcct tccgagaccc cgcggaggtc 300 ttcagggagt tcttcggggg ccacgaccct ttctccttcg acttcttcgg gggagacccc 360 cttgagaact tttttgggga tcggaggagc acccgtggaa gcagaagccg aggggctgta 420 cccttctcta cctcctttac cgaattccca ggatttgggg gtggcttcgc ttcgttagat 480 actggattca catccttcgg ttctccagga aactcgggcc tttcttcttt ctccatgtct 540 tgcggcggtg gggcggcagg caactacaag tcggtgtcaa cctccaccga aataattaat 600 ggcaaaaaaa tcaccaccaa gagaatcgtt gagaatggtc aagaaagggt ggaagtggaa 660 gaagatggag agttaaagtc cctgataatt aatggcaaag agcagctgct tcgcatcaat 720 actcagtaa 729 <210> 8 <211> 1125 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1125) <223> Mus musculus Ras-related GTP binding B (Rragb) <400> 8 atggaagaat ctgactccga gaaaaagaca gagaaagaga atgtgggccc aaaagtggag 60 cctcctctag gggagccgga aggatcgctt gggtgggcaa tgccaaatgc agccatgaag 120 aaaaaggtcc tgttgatggg taaaagtgga tctggtaaga ccagcatgag gtctattatc 180 tttgcaaatt atattgccag agacacacgt cgtcttggtg caacaatact agaccgtata 240 catagtcttc aaattaatag cagtttgagc acctactctc tcgtagactc tgttggaaat 300 acaaagacat ttgatgtaga acattctcat gttcgatttc tgggaaacct ggttttgaac 360 ctgtgggatt gtggtggaca agataccttc atggaaaatt atttcactag ccagcgtgac 420 aacatcttcc gaaatgtgga ggttctgatt tatgtctttg atgtggagag ccgtgaactt 480 gaaaaggaca tgcactacta tcagtcatgc cttgaggcta ttctgcagaa ttctccagaa 540 gccaaaatct tttgcttggt acacaaaatg gatttggtac aggaagatca gcgagacttg 600 atatttaaag aacgagaaga ggacttaagg cgtttatcgc gtccgctaga atgttcttgt 660 ttccgaacat ctatctggga tgaaactctg tataaggcat ggtccagcat tgtttatcag 720 ctgattccca atgttcagca actggaaatg aacctgcgga attttgctga aattattgag 780 gctgatgaag ttcttctgtt tgaaagagct acctttctgg tgatttctca ttatcagtgt 840 aaagaacagc gagatgccca ccgatttgag aaaatcagca acattattaa gcaattcaag 900 ctgagctgta gcaagctggc tgcctctttc cagagtatgg aagtgaggaa ctctaacttt 960 gctgctttca ttgacatatt cacatccaac acttacgtca tggtcgtgat gtctgatcca 1020 tccattcctt ctgcagctac tctgatcaac atccgcaatg ccagaaaaca ctttgaaaag 1080 ctggagagag tggatggacc aaaacagtgt cttctcatgc gctaa 1125 <210> 9 <211> 3165 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(3165) <223> Mus musculus NLR family, pyrin domain containing 12 (Nlrp12) <400> 9 atgttgccgt ctacagccag ggatggcctc tatcgactgt ctacctacct ggaagaactc 60 gaggctgggg aactgaagaa attcaaatta ttcctgggga ttgcagagga cctgagccag 120 gacaaaattc cctggggacg aatggagaag gctggtcctc tggaaatggc tcagctgatg 180 gtggcccaca tggggacaag ggaggcttgg cttctggctc tcagcacctt tcagaggatt 240 cacaggaagg acctgtggga gcgaggacag ggagaagacc tggtgagggt cactccaaat 300 aatggtctat gcctttttga gagccaatca gcgtgccctt tggatgtctc tcccaatgct 360 ccaagaaaag atctacagac aacctacaaa gactatgtcc gaaggaaatt ccagctaatg 420 gaagaccgca atgcacgatt aggcgaatgt gtgaacctga gcaatcgtta cactcggctt 480 ctcctagtaa aagaacactc aaatcctatc tggacacagc agaaatttgt agatgtagag 540 tgggaacgct ccagaaccag gcgtcaccag actagtccta tccaaatgga gaccctcttt 600 gagccagacg aagaacgccc cgagccacca cacacagtgg tattacaagg ggcagcgggg 660 atggggaagt ccatgctggc ccacaaagtg atgttggact gggccgatgg gaggctcttc 720 caaggccggt ttgattatgt cttctatatc agctgcaggg agttgaatag aagccacacc 780 cagtgcagtg tacaagacct catctccagc tgctggccgg agcgtggtat atccctcgaa 840 gacctcatgc aggctcctga ccgtctccta ttcatcattg atggcttcga taaactccat 900 ccttctttcc atgatgctca gggtccctgg tgcctctgct gggaggagaa acaacctact 960 gaagtcctcc tcggaagtct gattcggagg ttgcttctgc cccaggtctc tctgctcatc 1020 accacacgac cctgtgcact ggagaagctg cacggcttgc tagaacaccc caggcacgtg 1080 gagatcctgg gcttctccga ggaagctagg aaggaatatt tctacagata tttccacaac 1140 actggacaag caagccgggt gttaagcttc ttgatggact atgagcccct ctttaccatg 1200 tgttttgttc ccatggtgtc ctgggtggtc tgcacctgcc taaagcagca gctggaaagt 1260 ggggagcttt taagacaaac acctaggacc accacagctg tttatatgtt ctaccttctg 1320 agcctgatgc agcccaagcc agggactcca accttcaaag tcccagccaa ccagagaggc 1380 ctggtctctc tggctgcaga gggcctctgg aatcagaaga ttctatttga tgaacaggat 1440 cttgggaaac acggcctaga tggagcagat gtgtccactt tcctcaacgt gaacatattc 1500 cagaagggta tcaaatgtga gaaattctac agcttcatcc acctgagttt ccaggaattc 1560 ttcgcagcca tgtactgtgc actgaatggc agagaggcgg tgaggagagc gctggctgag 1620 tatggttttt cggaaaggaa cttcttggcc ctcacggtcc actttctgtt tggcctcctc 1680 aacgaagaga tgagatgcta ccttgagagg aatctcggct ggagcatctc ccctcaggtg 1740 aaggaggaag tgttggcatg gatccaaaac aaggctggga gtgaaggctc caccctgcag 1800 catggctccc tggagctact cagctgcttg tatgaggtcc aggaggagga cttcatccag 1860 caggccctga gccactttca agtggttgta gtcagaagca tctcaacaaa gatggagcac 1920 atggtctgct cgttttgtgc gaggtattgc agaagtacag aagtgcttca cttgcatggg 1980 agtgcttata gtacaggcat ggaggacgac ccaccagaac cttcaggagt ccagactcag 2040 tccacatact tacaggaaag gaacatgctg cctgatgtct acagtgcata cctttcagca 2100 gctgtctgta ccaactccaa cctgatcgag ctggccttat accgaaatgc cttgggcagc 2160 cagggtgtaa ggctgctctg tcaaggcctc cgacatgcca gctgcaagct gcagaacctg 2220 aggctgaaga ggtgtcagat ctccggatca gcctgccagg acctcgcagc cgctgtcatc 2280 gccaacagga atttaatcag gctggacctc agtgacaaca gcattggggt gccaggcctg 2340 gagctgctct gtgaggggct gcagcacccc aggtgtaggc tgcagatgat ccagctgagg 2400 aagtgtctgt tggaggctgc agctggccga tccctggctt ctgttctcag caacaactca 2460 tatctggtag aactggatct gacaggaaac cccttggaag attcggggct gaagttactg 2520 tgtcaagggc taaggcaccc tgtctgcagg ctgcgtaccc tgtggctgaa gatctgccac 2580 cttggacaag cttcctgcga agatctggcc tctactctca aaatgaacca gagcctgctg 2640 gagctggacc tgggtctgaa tgatcttgga gattctgggg tgcttctgct gtgtgaaggc 2700 ctcagtcatc cagattgcaa actccagacc cttcggttgg gcatttgccg actgggctca 2760 gtcgcgtgtg tggggatcgc cagtgtgctc caggtcaaca catgcctcca agagctggac 2820 ctgagcttca atgacttggg agacaggggc ctgcagctgc tgggggaagg cctgaggcac 2880 cagacctgca gactccagaa gctgtggctg gacaactgcg gactcacctc caaagcatgt 2940 gaggaccttt cttctatcct gggaatcagc cagaccctgc atgagcttta tttgaccaat 3000 aatgctctgg gggacacagg tgtctgtctg ctgtgcaaga ggctgaggca tccaggctgc 3060 aagcttcgag tcctgtggct gtttgggatg gacctgaata aaaagactca caggaggatg 3120 gcagcacttc gagtcacaaa accgtacctg gatattgggt gttga 3165 <210> 10 <211> 693 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(693) <223> Mus musculus triggering receptor expressed on myeloid cells 1 (Trem1) <400> 10 atgaggaagg ctgggctctg gggactgctg tgcgtgttct ttgtctcaga agtcaaagct 60 gccattgttc tagaggaaga aaggtatgac ctagtggagg gccagacttt gacagtgaag 120 tgtcccttca acatcatgaa gtatgccaac agccagaagg cttggcagag actaccagac 180 gggaaggaac ccttgaccct ggtggtcaca cagaggccct ttacaagacc cagtgaagtc 240 cacatgggga agttcaccct gaaacatgac cctagtgagg ccatgctaca agttcaaatg 300 actgaccttc aagtgacaga ctctggattg tatcgttgtg tgatttacca tcctccgaat 360 gaccctgttg tgctcttcca tcctgtccgc ctggtggtga ccaagggttc ttcagatgtg 420 ttcactcctg tcatcattcc tattacaagg ctgacagagc gtcccatcct tattaccaca 480 aaatactcac ccagtgacac aactacaacc cgatccctac ccaagcccac tgcggttgtt 540 tcctctcctg gtcttggagt cactatcata aatgggacag atgctgacag tgtctccaca 600 tccagtgtta ctatttcagt catctgtgga cttctcagca agagcctggt tttcatcatc 660 ttattcattg tcacaaagag gacatttgga tga 693 <210> 11 <211> 1404 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1404) <223> Mus musculus sialic acid binding Ig-like lectin E (Siglece) <400> 11 atgctgctgt tgctgctgct gctgctgctc tgggggataa agggtgtgga gggtcagaac 60 ccccaagagg ttttcaccct gaatgtggaa aggaaggtgg tggtgcagga gggcctgtgt 120 gtccttgtgc cctgtaactt ctcctatctc aagaagaggt tgactgactg gactgactca 180 gacccagttc atggattctg gtacagggaa ggaaccgaca gacgcaaaga ttccatcgtg 240 gccacaaata acccaattcg taaagcagtg aaggaaaccc ggaatcgatt cttcctgctc 300 ggagaccctt ggaggaatga ctgctccctg aacatcagag agatcagaaa gaaggatgcg 360 gggttatact tctttcgcct ggagcgtgga aaaacaaagt ataattacat gtgggacaag 420 atgactctgg ttgtaacagc cctcactaac accccccaaa ttcttctccc ggagacgctt 480 gaagctggcc atcccagcaa cctgacctgc tctgtgcctt gggactgtgg gtggacggca 540 cctcccatct tctcctggac tggtacctct gtgtcatttt tgagcaccaa cactacgggt 600 tcctcagtgc taaccatcac ccctcagcct caggaccatg gcaccaacct cacttgtcag 660 gtgaccctgc ctggaactaa tgtgtccaca agaatgacca tccgtctcaa cgtgtcatat 720 gctccaaaga atctgactgt gaccatctat caaggagctg actcagtttc cacaatcctg 780 aagaatggct catctcttcc tatctctgag ggccagtcac tgcgtctcat ctgcagcacc 840 gacagctatc cccctgcgaa cctaagctgg tcctgggata acctgaccct gtgcccatca 900 aagttgtcca agcccgggct cctggagctg tttccagtgc atcttaagca cggaggagtg 960 tatacctgcc aagctcaaca tgccctgggc tcccaacaca tttccttgag cctgtctcca 1020 cagagcagtg caactttatc tgaaatgatg atggggacct ttgtgggttc aggagtcaca 1080 gccctccttt tcctgtctgt ctgcatcctc ctcctggcag taagatccta caggaggaaa 1140 ccagccaggc cagctgtggt agctccgcac ccagatgccc tcaaggtctc agtttctcag 1200 aatcccctgg ttgaatccca ggcagatgac agctctgagc ccctgccttc catacttgag 1260 gcggccccct cctccacaga ggaagagata cattatgcga ccctcagctt tcacgagatg 1320 aagcccatga acctgtgggg gcaacaggac actaccacgg agtactcaga gataaagttt 1380 ccacaaagga ccgcatggcc atga 1404 <210> 12 <211> 318 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(318) <223> Mus musculus haptoglobin (Hp) <400> 12 atgagagccc tgggagctgt tgtcactctc ctgctctggg gtcagctttt tgctgtggag 60 ttgggcaatg atgccatgga ctttgaagat gacagctgcc caaagccccc agagattgca 120 aacggctatg tggagcactt ggttcgctat cgctgccgac agttctacag actacgggcc 180 gaaggagatg gggtgtacac cttaaacgac gagaagcaat gggtgaacac agtcgctgga 240 gagaaactcc ccgaatgtga ggcaggccaa gatgatctcc cgccacggac tcaccaccgg 300 ggccacgttg atcagtga 318 <210> 13 <211> 2193 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(2193) <223> Mus musculus matrix metallopeptidase 9 (Mmp9) <400> 13 atgagtccct ggcagcccct gctcctggct ctcctggctt tcggctgcag ctctgctgcc 60 ccttaccagc gccagccgac ttttgtggtc ttccccaaag acctgaaaac ctccaacctc 120 acggacaccc agctggcaga ggcatacttg taccgctatg gttacacccg ggccgcccag 180 atgatgggag agaagcagtc tctacggccg gctttgctga tgcttcagaa gcagctctcc 240 ctgccccaga ctggtgagct ggacagccag acactaaagg ccattcgaac accacgctgt 300 ggtgtcccag acgtgggtcg attccaaacc ttcaaaggcc tcaagtggga ccatcataac 360 atcacatact ggatccaaaa ctactctgaa gacttgccgc gagacatgat cgatgacgcc 420 ttcgcgcgcg ccttcgcggt gtggggcgag gtggcacccc tcaccttcac ccgcgtgtac 480 ggacccgaag cggacattgt catccagttt ggtgtcgcgg agcacggaga cgggtatccc 540 ttcgacggca aggacggcct tctggcacac gcctttcccc ctggcgccgg cgttcaggga 600 gatgcccatt tcgacgacga cgagttgtgg tcgctgggca aaggcgtcgt gatccccact 660 tactatggaa actcaaatgg tgccccatgt cactttccct tcaccttcga gggacgctcc 720 tattcggcct gcaccacaga cggccgcaac gacggcacgc cttggtgtag cacaacagct 780 gactacgata aggacggcaa atttggtttc tgccctagtg agagactcta cacggagcac 840 ggcaacggag aaggcaaacc ctgtgtgttc ccgttcatct ttgagggccg ctcctactct 900 gcctgcacca ctaaaggccg ctcggatggt taccgctggt gcgccaccac agccaactat 960 gaccaggata aactgtatgg cttctgccct acccgagtgg acgcgaccgt agttgggggc 1020 aactcggcag gagagctgtg cgtcttcccc ttcgtcttcc tgggcaagca gtactcttcc 1080 tgtaccagcg acggccgcag ggatgggcgc ctctggtgtg cgaccacatc gaacttcgac 1140 actgacaaga agtggggttt ctgtccagac caagggtaca gcctgttcct ggtggcagcg 1200 cacgagttcg gccatgcact gggcttagat cattccagcg tgccggaagc gctcatgtac 1260 ccgctgtata gctacctcga gggcttccct ctgaataaag acgacataga cggcatccag 1320 tatctgtatg gtcgtggctc taagcctgac ccaaggcctc cagccaccac cacaactgaa 1380 ccacagccga cagcacctcc cactatgtgt cccactatac ctcccacggc ctatcccaca 1440 gtgggcccca cggttggccc tacaggcgcc ccctcacctg gccccacaag cagcccgtca 1500 cctggcccta caggcgcccc ctcacctggc cctacagcgc cccctactgc gggctcttct 1560 gaggcctcta cagagtcttt gagtccggca gacaatcctt gcaatgtgga tgtttttgat 1620 gctattgctg agatccaggg cgctctgcat ttcttcaagg acggttggta ctggaagttc 1680 ctgaatcata gaggaagccc attacagggc cccttcctta ctgcccgcac gtggccagcc 1740 ctgcctgcaa cgctggactc cgcctttgag gatccgcaga ccaagagggt tttcttcttc 1800 tctggacgtc aaatgtgggt gtacacaggc aagaccgtgc tgggccccag gagtctggat 1860 aagttgggtc taggcccaga ggtaacccac gtcagcgggc ttctcccgcg tcgtctcggg 1920 aaggctctgc tgttcagcaa ggggcgtgtc tggagattcg acttgaagtc tcagaaggtg 1980 gatccccaga gcgtcattcg cgtggataag gagttctctg gtgtgccctg gaactcacac 2040 gacatcttcc agtaccaaga caaagcctat ttctgccatg gcaaattctt ctggcgtgtg 2100 agtttccaaa atgaggtgaa caaggtggac catgaggtga accaggtgga cgacgtgggc 2160 tacgtgacct acgacctcct gcagtgccct tga 2193 <210> 14 <211> 660 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(660) <223> Mus musculus C-type lectin domain family 4, member d (Clec4d) <400> 14 atgtggctgg aagaatccca aatgaaatca aaaggtaccc gacatcccca actgatccct 60 tgcgtcttcg ctgttgtttc catctcgttc cttagtgctt gctttatttc aacttgtttg 120 gtgactcatc attacttttt acgctggacg agaggaagtg tggtgaaact gtcagactac 180 cacacgagag taacgtgcat ccgagaggag ccacagcctg gagctacagg aggtacttgg 240 acctgctgtc ctgttagctg gagagccttc cagtctaact gttactttcc tcttaatgac 300 aaccagacct ggcatgagag cgagaggaac tgctcaggga tgagcagtca tctggtgacc 360 atcaacaccg aagcagaaca gaattttgtg acccagcttt tggataaacg gttttcttat 420 ttcctgggac ttgctgatga gaatgtggaa ggccaatggc agtgggtgga caagacgcca 480 tttaacccac acacggtatt ctgggaaaag ggggaatcca atgactttat ggaagaagac 540 tgtgttgtcc ttgttcatgt ccatgaaaaa tgggtctgga atgactttcc ttgtcacttt 600 gaggtgagaa ggatttgtaa attacctgga ataacattca attggaagcc ctcgaagtga 660 660 <210> 15 <211> 1341 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1341) <223> Mus musculus Kruppel-like factor 5 (Klf5) <400> 15 atgcccacgc gggtgctgac catgagcgcc cgcctgggac cactgcccca gccgccggcc 60 gcgcaggacg agcccgtgtt cgcgcagctc aagccggtgc tgggcgctgc gaacccggcc 120 cgcgacgcgg cgctcttctc cggagacgat ctgaaacacg cgcaccacca cccgcctgcg 180 ccgccgccag ccgctggccc gcgactgccc tcggaggagc tggtccagac aagatgtgaa 240 atggagaagt atctgacccc tcagctccct ccagttccga taatttcaga gcataaaaag 300 tatagacgag acagtgcctc agtggtagac cagttcttca ctgacactga aggcatacct 360 tacagcatca acatgaacgt cttcctccct gacatcactc acctgagaac tggcctctac 420 aaatcccaga gaccatgcgt aacacagatc aagacagaac ctgttaccat tttcagccac 480 cagagcgagt cgacggcccc tcctcctcct ccggccccca cccaggctct ccccgagttc 540 actagtatct tcagctccca ccagaccaca gcgccaccac aggaggtgaa caatatcttc 600 atcaaacaag aacttcctat accagatctt catctctctg tcccttccca gcagggccac 660 ctgtaccagc tgttgaatac accggatcta gacatgccca gttcgacaaa ccagacggca 720 gtaatggaca cccttaatgt ttctatggca ggccttaacc cacacccctc tgctgttcca 780 cagacgtcaa tgaaacagtt ccagggcatg cccccttgca cgtacaccat gccaagtcag 840 tttcttccac agcaggccac ctactttccc ccgtcaccac caagctcaga gcctggaagt 900 cccgatagac aagctgagat gctgcagaat ctcaccccac ctccgtccta tgccgctaca 960 attgcttcca aactggcgat tcacaaccca aatttacctg ccactctgcc agttaattcg 1020 ccaactctcc cacctgtcag atacaacaga aggagtaacc cggatctgga gaagcgacgt 1080 atccacttct gcgattataa tggttgcaca aaagtttata caaagtcgtc tcacttaaaa 1140 gctcacctga ggactcatac gggcgagaag ccctacaagt gcacctggga gggctgcgac 1200 tggaggtttg cccggtcgga tgagctgacc cgccactaca ggaagcacac gggcgccaag 1260 ccgttccagt gcatggtgtg ccaacgcagc ttctcccgct ccgaccacct cgcgctgcac 1320 atgaagcgcc accagaactg a 1341 <210> 16 <211> 2157 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(2157) <223> Mus musculus myeloperoxidase (Mpo) <400> 16 atgaagctac tcttggcctt ggcaggcctc ctggcccctc tggccatgct tcagacctcc 60 aatggtgcca ccccagctct cctgggggaa gtggagaatt cagttgtgct gagctgtatg 120 gaagaggcca agcagctagt ggacagagcc tacaaggagc ggagagaaag catcaagcgg 180 agcctccaaa gcggctctgc cagccccacg gagctcctgt tttacttcaa gcagccggtg 240 gcgggcacca gaacagctgt gagggccgct gattatctac atgtggccct agacctgctg 300 aagaggaagc tgcagcccct gtggccaagg cctttcaatg ttacagatgt gttgacacct 360 gctcagctga atctgttgtc cgtgtcaagt ggctgtgcct atcaggacgt gagggtgaca 420 tgcccaccga atgacaagta tcgcaccatc actggacact gcaacaacag acgaagcccc 480 actctggggg cctccaaccg tgcctttgta cgctggttgc ctgcagagta tgaagatggc 540 gtctccatgc cctttggctg gacgcctgga gtcaatcgca atggcttcaa ggtgcccctg 600 gctcgccagg tctccaatgc catcgtgcgc ttccccaacg atcagctgac caaggaccag 660 gagcgtgcac tcatgttcat gcagtgggga cagtttctgg atcatgatat caccttgact 720 ccagagccag ctacccggtt ctccttcttc actggcctca actgcgagac cagctgcctg 780 cagcagccac cctgcttccc cctcaagatc ccacccaatg accctcgaat caagaaccaa 840 aaggactgca tccccttctt ccgctcctgc ccggcatgca ccaggaacaa catcaccatt 900 cgcaaccaga tcaacgcgct cacttccttc gtggacgcca gcggggtgta cggcagcgag 960 gaccccctag ccagaaagct gcgcaacctc accaaccagc tggggctgct ggctatcaat 1020 acacgcttcc aagacaatgg cagggccctg atgccctttg acagcctgca cgatgacccc 1080 tgcctcctca ccaaccgctc cgcccgcatt ccttgttttc tggcagggga catgcgctcc 1140 agcgagatgc cggagctcac ctccatgcac accctctttg ttcgagagca taaccggctg 1200 gccacacagc tcaagcgcct gaatcctcga tggaatgggg agaagctcta ccaggaggcc 1260 cggaagattg taggggccat ggtccagatc atcacatacc gggactacct gcccttggtg 1320 ttggggccag cagccatgaa gaagtaccta ccccagtacc gatcttacaa cgactcagta 1380 gaccctcgaa tcgccaatgt cttcaccaac gctttccgtt atggccacac cctcatccaa 1440 cccttcatgt tccgcctgaa caatcagtac cggcccacag ggcccaaccc ccgagtccca 1500 ctcagcaagg tcttttttgc cagctggaga gtcgtgttgg aaggtggcat tgaccccatc 1560 ctccgaggcc tcatggccac tccagccaaa ctgaatcgcc agaatcaaat tgtggtggat 1620 gagatccggg agcgactatt tgagcaagtc atgaggatag gactggattt gcctgctctt 1680 aacatgcagc gcagccggga tcacggcctc ccaggataca atgcctggag acgcttttgt 1740 gggcttccac agcccagcac agtgggtgag ctcggcacgg tgctgaagaa cctggagttg 1800 gcacggaagc tgatggcaca atatggcacg cccaacaaca ttgacatctg gatgggcggt 1860 gtgtccgagc ccctggagcc caatggccgt gtaggccagc tccttgcctg cctcattggc 1920 actcagttta ggaagctacg tgatggtgat cggttttggt gggagaaccc aggcgtgttc 1980 agtaaacagc agagacaggc cttggccagc atctccttgc cccgtatcat ctgtgacaac 2040 actggcatca ccaccgtgtc gaagaacaac atcttcatgt ccaacacata cccccgagac 2100 tttgtcagct gtaacaccct tcctaaactg aacctgactt cctggaagga gacctag 2157 <210> 17 <211> 1206 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1206) <223> Mus musculus glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (Gcnt2) <400> 17 atgcctccgt ccgtgcgtta cttcttcata gtgtctgtga ctactgtcat cgtttttatt 60 gtgctctacg tgttaagttt tggaggagat caaagctacc agaagctgaa catctcagac 120 tcggtgatgc tggctcaagt gtgctcatct ttcatcgacg ggaaaagccg gttcctgtgg 180 agaaacaaac taatgattca cgagaagcct tcttgcacag aatatgtgac ccaaagccac 240 tatatcactg cccctttatc tcaggaagag gtcgattttc ctttggcgta tgtcatggtc 300 atccatcaca attttgacac ctttgcaagg ctcttcaggg caatcttcat gcctcaaaat 360 atctactgtg ttcacgtgga tgaaaaggca acagctgaat tcaaaggtgc cgtggaacag 420 ttagtgagct gcttccccaa tgcctttctg gcttctaaga tggagccggt ggtctatggt 480 ggaatctccc ggctccaggc tgacctgaac tgcatcaaag acctgtccac ctccgaggtc 540 ccctggaagt acgccatcaa cacctgtgga caagacttcc ccctgaaaac caacaaggag 600 atagttcagt acctgaaagg gcttaagggg aagaacctca ctcccggggt gctgcctcca 660 gcccacgcca ttggaaggac caggtacgtc caccgggaac acctaagcaa agagctttcc 720 tacgtgatca gaaccacggc tctgaagccc ccacctcccc acaacctcac catttatttt 780 ggctctgcct atgtcgccct gtcgagagag tttgctaact ttgttctccg tgacccacgg 840 gcggttgatt tgctccattg gtccaaagat actttcagtc ccgatgagca tttctgggtg 900 acgctcaata ggattccagg agtccctggc tccatgccac caaacgcatc ctggacgggt 960 aacctcagag ctgtgaagtg gatggacatg gaagcgaagc atggaggctg ccatggtcac 1020 tacgtccatg gcatttgtat ctatggaaac ggagacttgc agtggctgat taattcgcaa 1080 agcctgtttg ctaacaaatt tgaactcaac acataccctc ttaccgtgga atgcctggaa 1140 ctgaggcttc gagaaagaac actcaaccag agtgagatcg ccatacagcc gagctggtat 1200 ttctga 1206 <210> 18 <211> 351 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(351) <223> Mus musculus chemokine (C-C motif) ligand 6 (Ccl6) <400> 18 atgagaaact ccaagactgc catttcattc tttatccttg tggctgtcct tgggtcccag 60 gctggcctca tacaagaaat ggaaaaagaa gatcgtcgct ataaccctcc aataattcat 120 caaggctttc aagacacttc ttcagactgc tgcttctctt atgccacaca gatcccatgt 180 aaaagattta tatattattt ccccaccagt ggtgggtgca tcaagccggg catcatcttt 240 atcagcagga ggggaaccca ggtctgtgcc gaccccagcg atcggagagt tcagaggtgc 300 ctaagcaccc tgaagcaagg cccaagatct gggaacaagg tcattgcttg a 351 <210> 19 <211> 1584 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1584) <223> Mus musculus receptor accessory protein 6 (Reep6) <400> 19 atggacggtc tgcgccagcg cttcgaacgt tttctggaac agaagaacgt ggccaccgaa 60 gcgctcgggg cgctcgaagc aaggaccggt gtagagaagc ggtatctcgc cgcgggagcc 120 ctcgcccttc taggcctgta tcttctgttc ggttacgggg cctctctact gtgcaatgtc 180 atcggatttg tataccccgc atatgcttca gtcaaagcta tcgagagccc aagcaaggaa 240 gacgacactg tgtggctaac ctactgggtg gtgtacgccc tgttcggtct ggtcgaattc 300 ttcagcgatc tactcctgtt ctggttccct ttctactacg cgggcaagtg cgccttcctg 360 ttattttgca tgacgcccgg accctggaac ggggcattac tactatacca tcgcgtcata 420 agaccactct ttctaaagca ccacatggct ctagacagcg ccgcgagcca gctaagcgga 480 agagcattgg acctagcagc tgggataacc cgggacgtac ttcaggcctt ggctcggggc 540 cgggctctcg tcaccccagc atcaacatcg gaacccccag ccgctctgga actggaccgt 600 atccaagtaa agtcagaccc cactcctgaa ccacaagtga ggaggtctgc tggcagtctg 660 tgtgcggatt ccccagccaa tgacaaggaa cgcacagctg ataatgtcca ggcctctgac 720 agttcttcag actcccagac aaagacacca ctgcaaccac agcctcagcc acaaccgcaa 780 ccgcaaccac aaccacaacc acaaccacaa ccacaaccac aacgccgaac ctcaagccca 840 agtaagacag taggaagccc ctcacgggcc acgaatgggc agtccccgtc cccagtcagc 900 ccaggccctg catctgtatc ccggggtcag ctggccactg tttctgccag cggctcccag 960 attcccagca agtcccggcc ccatcgcagc cggggcagtt tgactcccag ggctgcacag 1020 cgtgcccgac tgcccagtgg gactctgggc tccgctcagc tgcccatgcg ctcgggaggt 1080 gcctcccagc cagcaggccg gaccttggga cacaatcgca caacaggccg ccacacggga 1140 acaaaccacc agacccctca ggtctccgcc acaggccgat cggcagccgc agcaacagcc 1200 tccgcagcag ccccagcagc cccagcagcc ccagcagcag cagcgccagc agccacaact 1260 gcacccactt ccacacagcg tgtcagtgtc tccgcccagg actcacctag ggcccagtct 1320 cccagcacat cccctgaccc caaccaggct ggcagcaagg ctcctgtgga gccaggggac 1380 gcaggttcca agaacaagca gggccagaag acacaggtgg ccggcacctc agcaccctcc 1440 gaggcactgg tcccctgtca ctctgattcc tctctggatt atttgtccga gtctaccacg 1500 gagatcacct gtaaatggcc acagtatagt caccagctgc gttgccccag acactgctgg 1560 cttttgccac atctggcata ctag 1584 <210> 20 <211> 3225 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(3225) <223> Mus musculus elastin microfibril interfacer 2 (Emilin2) <400> 20 atgtgtcagg agaccccgcc ccgaccccga gcacccagtc gctggacgcc ggccctgctg 60 gccctgctgg ccctgggcgg cgcgggactg tgccacgcga gctcgcagcc tgggtaccac 120 gcgaggccca gtgccaggaa caaaaactgg tgcgcctaca tcgtgaataa gaacgtgagc 180 tgcacggtac aggagggaag cgagagtttt attcaagctc agtacaactg tccctggaac 240 cagatgccct gtccatccgc cctggtgtat cgggtaaact ttagacccag atttgtcact 300 agatacaaga tagtgacaca gttggaatgg agatgctgtc ctggctttag aggaccagac 360 tgccaagaag gtcccaaaga ccacatgaag accccccggc ccccatcagc tcgaccaaaa 420 aacaacctga agaaagccac agatacagat ccaagccaag tttctcagcc taagaaaacg 480 ttgtccccaa caaatgcagt ggaaccaggt caggttgcag atgcaaagca aggccctccg 540 gaacttcagc aatccaaagt ccaggtgctg gaggagaagg tcgtccgact caccaggatg 600 gtgctggatc tccagtccac cgtggtaggc ctgaaggaga acctcaaaca caccattcaa 660 gatgatggca gaaaagagcc agactcctgg ctcggtcccc tgcacccaca gccaacgcct 720 gacagccccc ttgcggggga cgcagagccg agccagcttc ccggaatccc cagcagcaag 780 gaatctggta tgaaggacat caagtctgag ttggctgagg tcaaagacac actgaagacc 840 aagagtgaca agctagaaga gctggacggg aaggtgaagg gctatgaagg acagctcaag 900 cagctgcagg aggcggctca gggtcccacg gtcaccatga caaccaatga gctgtaccaa 960 gcctatgtgg atagcaagat cgatgccctg agggaggagc tcatggaagg catggaccgg 1020 aagctggctg acctgaagaa tacgtgcgag tacaagctgg tggggctcca gcagcagtgt 1080 gatgactacg gcagcagcta cctcggagtg atagagctga tcggggagaa ggaggcgagc 1140 ctgaaaaaag acattgctga cctgcgagcc cagctgcagg atcctgtagc ccaaccaagc 1200 tgttgcaatg gtcaaaagag cagcgatttc ggcccacaga tcaaggcgct agaccagaaa 1260 atcgagagag ttgccgaggc caccaggatg ctgaatggac ggctggacaa tgagttcgac 1320 cgcctctccg ttccagagcc agacgcagac tttgatgcga gatggaccga gctcgacgca 1380 aggatcaatg tgacggagaa gaacgcagag gagcattgct tttacattga ggagaccctg 1440 cgggggacca tcaacggcga agtggatgac ttgaggaagc ttctgaatga gaagatccac 1500 tccctggaag accgtctggg aattgttctg caagcggcta acagctcaga cgtggagttg 1560 acacccatgg gcccagcctt gccagagcag ccaggggcag agaatgagca ggtcctaatg 1620 gagttgagcc gcctgaagga caaagttcaa gtggttgagg acttctgcct gcagagcttg 1680 ccccacggga tagatggagc tttgcctagt gtagaggacc tcacgcatgt cagcctgagc 1740 cttttagaat ccctcaatga tacgatgcac aggcagttcc aagaaacgag tcacagcatc 1800 cagaaactcc aagaggacgt caatgccctc cattctcaac tgaatcactc cgaatgtacg 1860 gggacttact tgcagaacgg agtgagcgac agccgaacag gtgacagcat ggaagcaagt 1920 gggtttacta agacagggga gcaagagagg acagtgggga ctgtcccgtc tcctgggacc 1980 cccgcggctc catgctgtgg tcagctggag gagcgctggc agaagctgca gaaccaaatg 2040 ttggctgagc tagacacgtg taaggagagt gctcacgggg ttcagagtgg ggtgtctgcg 2100 atcgagggca gggtgttcca gctggagcag acatgcagaa ggctggatac catctcaggg 2160 agtctgcaga ggatcaagga ggggctcggt aagcatgtgg gcagcttgtg gaactgcatc 2220 cggcagatga acgggacgct caaatcgcac tccagagaca tctctggcct caagaattct 2280 gtgcagcaat tctatagcca tgttttccag atttctaccg acttgcaaga tctggtcaag 2340 tttcagccat cagcaacaga ggaaccctca gaagcaaccg agggaccgtc tgggaagact 2400 cccctagaat ccaccagacc ttcagaggag gcccccactg aaccaccccg gctgacccca 2460 ctgccagaag accctgcagg accaccacag acaggccagc agccagtatt gccccagagg 2520 cccctgcagc caccaccttt gcctgcctgg cctggtcgca cggggttgcc cttcttgcct 2580 ggctctagtg gcgtcatcat ggagactgga gaggcggggc ctccaggcag gatgggcgtg 2640 tccggaaggg gcctgcctcg gggagtggat ggccagatgg ggcaggggcc cattcatagc 2700 tcggaaggct atgcaggggc accaggctac cccaagtcac ctcctgtaac caccccaggg 2760 gtgccgctgc ccactctggt gtccttttca gccggtctta cccagaagcc ttttcccagc 2820 gatggaggcg ttgttctctt caataaggtg ctggtgaacg atggggatgt atacaacccc 2880 aacactggga tcttcaccgc accatacgac gggcgctact tgatcacagc caccctcacc 2940 cctgagagag acacctatgt ggaagccgtc ctgtctgtct ccaacgccag tgttgcccag 3000 ctgcacacgg ctgggtacag gagagagttc ctggaatacc atcgtccccc tggggctgtg 3060 catacctgtg ggggcccggg ggccttccac ctcattgtgc acttgaaggc aggagatgga 3120 gtcaatgttg tggtgactgg gggcagactg gctcacacag actttgatga aatgtactcc 3180 accttcagtg gtgttttctt gtaccctttc ctttctcacc tctag 3225 <210> 21 <211> 1068 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1068) <223> Mus musculus chemokine (C-C motif) receptor 1 (Ccr1) <400> 21 atggagattt cagatttcac agaagcctac cccacaacta cagaatttga ctatggggac 60 tccactccat gccaaaagac tgctgtaaga gcctttgggg ctggactcct gccccccctg 120 tattctctag tgttcatcat tggagtggtg ggcaatgtcc tagtgattct ggtgctcatg 180 cagcatagga ggcttcaaag catgaccagc atctacctgt tcaacctggc tgtctctgat 240 ctggtcttcc ttttcacttt acctttctgg attgactaca agttgaaaga cgactggatt 300 tttggtgatg ccatgtgcaa gcttctctct gggttttatt acctgggttt atacagtgag 360 atcttcttta tcatcctgtt gacgattgac agatacctgg ccattgtcca tgctgtgttt 420 gccctgaggg cccgaactgt tacttttggc atcatcacca gtattatcac ctgggcccta 480 gccatcttag cttccatgcc tgccttatac ttttttaagg cccagtggga gttcactcac 540 cgtacctgta gccctcattt cccctacaag agcctgaagc agtggaagag gtttcaagct 600 ctaaagctaa accttcttgg actaattttg cctctgttag tcatgataat ctgctatgca 660 gggatcatca gaattctgct cagaagaccc agtgagaaga aggtcaaagc cgtgcgtctg 720 atatttgcta ttactcttct attcttcctc ctctggaccc cctacaatct gagtgtattt 780 gtttctgctt tccaagatgt tctattcacc aatcagtgtg agcagagtaa gcaactggac 840 ctggccatgc aggtgactga ggtgattgcc tacacccact gttgtgtcaa cccaatcatt 900 tatgtttttg tgggtgaacg gttctggaag taccttcggc agctgtttca aaggcatgtg 960 gctataccac tggcaaaatg gctgcccttc ctctctgtgg accaactaga aaggaccagt 1020 tctatatctc catccacagg agaacatgag ctctctgctg gcttctga 1068 <210> 22 <211> 657 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(657) <223> Mus musculus RAB27B, member RAS oncogene family (Rab27b) <400> 22 atgactgatg gagactatga ttatctgatt aaactcctgg cccttggaga ctcaggagtc 60 gggaagacaa catttctcta tagatacaca gacaataaat tcaatcccaa attcatcacc 120 acagtgggaa tagattttcg ggaaaaacgt gtggtttatg acacacaagg agcagatgga 180 gcgtcaggaa aagcgtttaa ggtacatctg cagctttggg acactgctgg acaagagcgg 240 ttccggagcc ttaccactgc cttcttcaga gatgccatgg gcttcttact gatgtttgac 300 ctcaccagtc aacagagctt cttgaatgtc agaaactgga tgagtcaact gcaggcaaat 360 gcttactgtg aaaacccaga catagtatta attggcaaca aggcagacct gccagaccaa 420 agggaagtca atgaacggca agcacgggag ctggctgaaa aatatggcat accatacttc 480 gaaacaagcg cagctacagg acagaatgta gagaagtcag tggaaacgct tctggactta 540 atcatgaaga gaatggaaaa gtgtgtagag aagacacagg ttccggacac tgtcaatgga 600 ggaaattctg gaaagctgga tggggaaaag ccagcagaaa agaaatgtgc ctgctag 657 <210> 23 <211> 1122 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(1122) <223> Mus musculus purinergic receptor P2Y, G-protein coupled 1 (P2ry1) <400> 23 atgaccgagg tgccttggtc ggttgtcccc aacgggacgg atgctgcctt tctggcgggc 60 ctgggctcgc tttggggaaa cagtactgtc gcctcaactg cagcagtttc ctcttcattc 120 caatgtgccc tgaccaagac cggtttccag ttctactacc tgccggctgt ctacatttta 180 gtgttcatca taggcttcct aggcaacagc gtggctatct ggatgttcgt tttccacatg 240 aagccttgga gcggcatctc cgtgtacatg ttcaatttgg ctctggctga ctttttatac 300 gtgctcaccc taccagccct catcttctac tacttcaaca agactgactg gatcttcggg 360 gatgctatgt gcaagctgca gagattcatc ttccacgtaa atctctacgg tagcatcttg 420 ttcctcacct gcatcagcgc acacaggtac agtggcgtgg tgtaccctct caagtctctg 480 ggcaggctca agaagaagaa tgccatttat gtcagcgtgc tggtgtggct cattgtggtg 540 gtggccatct cccctattct cttctactct ggcactggga ctcggaaaaa caaaactgtc 600 acctgctatg acaccacgtc caatgattac ctgcgaagtt atttcatcta cagtatgtgc 660 acgactgtgg ccatgttctg catccctttg gtgctgatct tgggctgtta tggattaatt 720 gttaaagctt tgatttacaa tgacctggac aactctccgc tccggaggaa atccatttac 780 ctggtgataa ttgtcctgac ggtgtttgct gtgtcttata tccctttcca tgtgatgaaa 840 acgatgaatt tgcgagcacg gttggatttc cagaccccag aaatgtgtga tttcaacgac 900 agggtttatg ccacttatca ggtaacaaga ggtctagcaa gtctcaacag ctgtgtggac 960 cccattcttt atttcttggc tggagataca ttcagaagga gactgtcccg agccaccagg 1020 aaagcttcca ggaggagtga ggccaattta caatccaaga gtgaagaaat gactctcaat 1080 attttatctg agttcaagca gaatggagac acgagtttgt ga 1122 <210> 24 <211> 3174 <212> RNA <213> Mus musculus <220> <221> mRNA <222> (1)..(3174) <223> Mus musculus protocadherin 10 (Pcdh10) <400> 24 atgattgtgc tgttattctt tgccttgctc tggatggtgg acggagtctt ttcccagctt 60 cattatactg tgcaggaaga gcaggaacat ggcactttcg tggggaatat cgctgaagac 120 ctgggcttgg acattacaaa actttcagct cgcaggtttc agacggtggc caactcacgg 180 accccttact tggacctcaa tctggagacc ggggttctgt acgtaaacga gaagatagat 240 cgcgagcaaa tctgtaagca gagcccctct tgtgtcctgc acctggaggt ctttctggag 300 aacccgctgg agctgttccg agtggagatc gaagtgctgg acatcaatga caaccctccc 360 tccttcccag agcccgacct gacagtggag atctcagaga gcgccacgcc aggcacccgc 420 tttcccttgg agagcgcctt cgacccagac gtggggacca actccttgcg agactacgag 480 ataaccccaa atagctactt ctcgctagac gtacagaccc agggagatgg caaccgattc 540 gccgaactgg tcctggagaa gccactggac cgagaacagc aagcggtgca ccgctacgtg 600 ctgaccgcgg tggacggggg aggaggggga ggaggagggg aaggaggggg aggcggtggg 660 ggagccggcc tgccccccca gcagcagcgt actggcacgg ccttgctcac catccgagtg 720 ctcgactcca acgacaatgt gcccgctttt gaccaacccg tctacacagt ttccctacca 780 gagaattctc cccctggcac gctagtgatc cagcttaatg ccaccgaccc tgatgaaggc 840 cagaatggcg aggtcgtgta ctcgttcagt agtcacattt cacccagggc tcgggagctc 900 ttcggactgt cgccgcgcac cggccggctg gaggtgagcg gcgagctgga ctatgaagag 960 agcccagtgt atcaggtgta tgtccaagcc aaggacttgg gtcccaatgc tgtgcctgcg 1020 cactgcaagg ttctggtgag agtgctggat gccaacgaca acgcaccaga gatcagcttc 1080 agcacagtga aagaggcggt gagcgagggt gcggcccctg gcacggtggt ggctctgttc 1140 agcgtgaccg atcgggactc agaggagaac gggcaggtgc agtgtgagct tctgggagac 1200 gtgccgttcc gcctcaagtc ttccttcaag aattactaca ctatcgtgac cgaagccccc 1260 ttggaccgag aggctgggga ctcctacacc ctgaccgtgg tggcccgcga ccggggcgag 1320 cctgcactct ccaccagtaa gtcgatccag gttcaagtgt cagatgtgaa tgacaatgcg 1380 ccgcgcttca gccagccggt ctacgacgtg tatgtgacag aaaacaatgt gccgggtgcc 1440 tacatttacg cggtgagcgc cacggaccgc gacgaagggg ccaatgcaaa attaacctac 1500 tctatcctag agtgccagat ccaaggaatg agtgtcttca cctacgtgtc catcaactca 1560 gacaacggct acttgtacgc cctgagatcc ttcgactatg agcagatcaa ggacttcagc 1620 tttcaagtag aagcccggga cgccggcagt ccccaggcgc tggccggcaa tgccacggtc 1680 aacatcttga tagtggatca gaacgacaac gcccccgcca tcgtggcgcc ccttccgggg 1740 cgcaacggga ctccagcccg cgaggtgctg ccgcgctctg ccgaacccgg ctacctgctc 1800 actcgtgtgg ccgcagtgga cgcggacgac ggcgagaacg ccaggctcac ctacagcata 1860 gtgcggggca acgaaatgaa cctctttcga ctggactggc gcaccggaga gctccgcacc 1920 gcgcgccggg tcccagccaa gcgcgacccc cagcggcctt atgagctggt gatcgaggtg 1980 cgcgaccacg ggcagccgcc cctgtcctcc acagccaccc tggtggttca gctggtggat 2040 ggagcggtgg agccacaggg cgggggcggg gaccgaggcg gagggtctgg ggaacacctg 2100 cgtcccagcc gctctggcgg cggggaaact tcactggacc tcacacttat ccttatcatc 2160 gccctgggct cggtgtcctt catcttcctg ctggccatga tcgtgttggc cgtgcgctgt 2220 cagaaagaga aaaaactcaa catctacacg tgtctcgcga gcgattgctg cctctgctgc 2280 tgctgctgcg gcaatgggag ctccacctgc tgcggccgcc aagcccgggc gcgcaagaag 2340 aaactcagca agtcagatat catgttggtg cagagcgcca acgtccctag caacccggcc 2400 caggtgccgg tagaggagtc cggaggcttc ggttcccatc accacaatca gaactattgc 2460 tatcaggtct gcctcacccc ggagtccgcc aagaccgacc tgatgttcct gaagccctgc 2520 agcccttccc ggagtacaga tgctgagcac aatccctgcg gagccatcgt caccgggtac 2580 agcgaccagc aaccagacat catttccaac ggaagcattt tgtccaacga gaataaacac 2640 cagcgagcag agctcagcta tctagttgac agacctcgcc gagttaacag ttctgcattc 2700 caggaagctg acatagtaag ctctaaggac agtggtcatg gagacagtga acagggagac 2760 agtgatcatg atgtcaccaa ccgtggccag tcagctggta tggatctttt ctccaactgc 2820 accgaggaat gtaaagcact gggccactct gaccgatgct ggatgccttc ttttgtccct 2880 tcggatggac gccaggctgc agattaccgc agcaacctgc atgtccccgg catggactct 2940 gttccagaca ccgaggtctt tgaacctcca gaagtccagc ctggggcaga gcgctccttc 3000 tccactttcg gcaaagagaa ggccctgcat ggcaccctgg agaggaagga gttggacgga 3060 ttgctgtcta atacacgagc gccttacaaa ccaccatatt tgaaaatgct gtggatgcag 3120 ctgcgtggag aggctcattt aacgaaagat ggaggcaagc aaacaaccac atga 3174

Claims (7)

  1. C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Clec4d, Klf5, Gcnt2, Ccl6, Reep6, Ccr1, Rab27b, P2ry1 및 Pcdh10으로 이루어진 유전자 군을 검출하기 위한 물질을 포함하는 저선량 방사선 피폭 진단용 조성물로서,
    상기 저선량 방사선은 누적 선량이 0.1 Gy 인 것을 특징으로 하는 저선량 방사선 피폭 진단용 조성물.


  2. 삭제
  3. 동물로부터 분리된 시료에서 C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Clec4d, Klf5, Gcnt2, Ccl6, Reep6, Ccr1, Rab27b, P2ry1 및 Pcdh10으로 이루어진 유전자 군의 발현 수준을 측정하는 단계를 포함하는 저선량 방사선 피폭 진단을 위한 정보 제공 방법으로서,
    상기 저선량 방사선은 누적 선량이 0.1 Gy 인 것을 특징으로 하는 저선량 방사선 피폭 진단을 위한 정보 제공 방법.
  4. 제3항에 있어서,
    상기 C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Clec4d, Klf5, Gcnt2, Ccl6, Reep6, Ccr1, Rab27b, P2ry1 및 Pcdh10 으로 이루어진 유전자 군은 그 발현 수준이 저선량 방사선에 피폭되지 않은 대조군에 비해 1.5배 이상 증가한 경우 저선량 방사선에 피폭되었다고 진단하는 것을 특징으로 하는 저선량 방사선 피폭 진단을 위한 정보 제공 방법.


  5. 삭제
  6. C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Clec4d, Klf5, Gcnt2, Ccl6, Reep6, Ccr1, Rab27b, P2ry1 및 Pcdh10으로 이루어진 유전자 군을 바이오 마커로 포함하는 저선량 방사선 피폭 진단용 DNA 칩으로서, 상기 저선량 방사선은 누적 선량이 0.1 Gy 인 것을 특징으로 하는 저선량 방사선 피폭 진단용 DNA 칩.
  7. C1qtnf2, Dsg1a, Tmprss13, Popdc3, Dnajb3, Rragb, Nlrp12, Trem1, Siglece, Hp, Clec4d, Klf5, Gcnt2, Ccl6, Reep6, Ccr1, Rab27b, P2ry1 및 Pcdh10유전자 각각에 특이적으로 결합하는 프라이머 또는 프로브를 모두 포함하는 저선량 방사선 피폭 진단용 키트로서,
    상기 저선량 방사선은 누적 선량이 0.1 Gy 인 것을 특징으로 하는 저선량 방사선 피폭 진단용 키트



KR1020190070083A 2019-06-13 2019-06-13 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용 KR102198970B1 (ko)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020190070083A KR102198970B1 (ko) 2019-06-13 2019-06-13 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020190070083A KR102198970B1 (ko) 2019-06-13 2019-06-13 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용

Publications (2)

Publication Number Publication Date
KR20200142783A KR20200142783A (ko) 2020-12-23
KR102198970B1 true KR102198970B1 (ko) 2021-01-06

Family

ID=74089199

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190070083A KR102198970B1 (ko) 2019-06-13 2019-06-13 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용

Country Status (1)

Country Link
KR (1) KR102198970B1 (ko)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150038351A1 (en) * 2012-09-11 2015-02-05 The Regents Of The University Of California Gene Signatures That Predispose Or Protect Individuals From Low-Dose Radiation Induced Breast Cancer Or Are Associated with Disease-Free Survival
JP2019069996A (ja) 2013-07-09 2019-05-09 エスアールアイ インターナショナルSRI International 放射線傷害の線量評価のためのバイオマーカーパネルおよびマイクロ血漿フィルター

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101885596B1 (ko) * 2016-09-02 2018-08-06 한국원자력의학원 방사선 피폭 진단용 조성물 및 이를 이용한 방사선 피폭 진단방법
KR101974914B1 (ko) * 2016-10-28 2019-05-07 한국수력원자력 주식회사 저선량 방사선 특이적 반응인자 Ikaros를 이용한 하위조절 유전자 탐색 및 그 스크리닝 방법
KR102034828B1 (ko) * 2017-09-26 2019-11-08 한국수력원자력 주식회사 저선량률 저준위 방사선 조사된 쥐 흉선 림프종 세포에서 발굴된 텔로미어 조절 유전자군과 그 검출방법

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150038351A1 (en) * 2012-09-11 2015-02-05 The Regents Of The University Of California Gene Signatures That Predispose Or Protect Individuals From Low-Dose Radiation Induced Breast Cancer Or Are Associated with Disease-Free Survival
JP2019069996A (ja) 2013-07-09 2019-05-09 エスアールアイ インターナショナルSRI International 放射線傷害の線量評価のためのバイオマーカーパネルおよびマイクロ血漿フィルター

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
Oncotarget (2018) 9(41):26387-26405*
Proteomes (2015) 3:132-158*
박수진 등, "동물모델 면역조직에서 저선량방사선 특이적 Ikaros 인산화에 의해 조절되는 유전자들", 2018년도 대한방사선방어학회 춘계 학술발표회 논문요약집, pp.358-359 (2018)
임지혜 등, "저선량 방사선에 특이적으로 변화하는 단백질 스크리닝", 2015년도 대한방사선방어학회 추계 학술발표회 논문요약집, pp.142-143 (2015)

Also Published As

Publication number Publication date
KR20200142783A (ko) 2020-12-23

Similar Documents

Publication Publication Date Title
DK2681333T3 (en) EVALUATION OF RESPONSE TO GASTROENTEROPANCREATIC NEUROENDOCRINE NEOPLASIS (GEP-NENE) THERAPY
DK2644713T3 (en) A Method for Diagnosing Neoplasms II
KR102357699B1 (ko) 발현 프로파일링에 의한 림프종 유형의 하위유형 분류 방법
RU2721916C2 (ru) Способы прогнозирования рака предстательной железы
KR101545020B1 (ko) 식도암 및 식도암 전이 진단을 위한 조성물 및 방법
KR101446626B1 (ko) 신장암 진단, 신장암 환자 예후 예측을 위한 조성물 및 방법
US6773883B2 (en) Prognostic classification of endometrial cancer
KR101421326B1 (ko) 유방암 예후 예측을 위한 조성물 및 이를 포함하는 키트
WO2003042661A2 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
CN109790583A (zh) 对肺腺癌亚型分型的方法
AU2016331663A1 (en) Pathogen biomarkers and uses therefor
KR20100095564A (ko) 항-cd40 항체를 사용한 치료에 대한 b-세포 림프종의 반응성 평가를 위한 방법 및 조성물
CN109863251A (zh) 对肺鳞状细胞癌亚型分型的方法
CN101573453A (zh) 使用生物学途径基因表达分析来预测淋巴结阴性原发性乳腺癌的远处转移的方法
AU2017334293A1 (en) Assay for distinguishing between sepsis and systemic inflammatory response syndrome
CN101111768A (zh) 肺癌预后
JP2003304888A (ja) 化合物の毒性予測のための方法
DK3201630T3 (en) Multiplex assay for simultaneous detection of TP53 / CEN17 / B cell gene protein and uniquely specific probes for 19Q12, INSR, ATM, DLEU2, TP53 and 13Q12
AU2016377391A1 (en) Triage biomarkers and uses therefor
KR20140014642A (ko) 노닐페놀 노출에 대응하는 바다송사리 유전자 및 이를 이용한 수생태계 환경오염 진단 방법
KR102198970B1 (ko) 저선량 방사선에 특이적으로 반응하는 지표 유전자군의 발굴 및 이의 응용
US20020137077A1 (en) Genes regulated in activated T cells
CN108779496B (zh) 罹患食管基底细胞样鳞状细胞癌的鉴别方法
EP1497454A2 (en) Methods of diagnosis of cancer, compositions and methods of screening for modulators of cancer
AU2016349950A1 (en) Viral biomarkers and uses therefor

Legal Events

Date Code Title Description
AMND Amendment
E601 Decision to refuse application
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)
GRNT Written decision to grant